Current status and future potential of transdermal drug delivery

By Mark R. Prausnitz, S. Mitragotri, R. Langer. Nature reviews. Drug discovery, 2004

1,447 citations recorded by the source corpus.

Subfields: Immunology, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/9965c8cbb929fa3b532de9ca29ce813b4b501453

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Mark R. Prausnitz
2. Robert Langer
3. Jung-Hwan Park
4. R. Donnelly
5. A. Woolfson

In Pharmaceutical Science

1. Mark R. Prausnitz
2. Robert Langer
3. H. Gill
4. R. Donnelly
5. Jung-Hwan Park
6. K. van der Maaden
7. W. Jiskoot
8. J. Bouwstra

Citations in the corpus

• Transdermal drug delivery (2008, background): “1504" language="eng" publish="issue" relation="no"> Transdermal delivery represents an attractive alternative to oral delivery of drugs and is poised to provide an alternative to hypodermic injection, to”
• Coated microneedles for transdermal delivery. (2007, background): “017 especially attractive alternative, because it is usually easy to use, safe, and painless [5,6].”
• Drug Delivery Systems and Materials for Wound Healing Applications (2018, neutral): “In these systems, an externally triggered module drives the drug towards the skin or through that [245].”